Your session is about to expire
← Back to Search
ICS/LABA Therapy for Asthma Non-adherence
Study Summary
This trial aims to improve adherence to maintenance inhalers in asthmatic patients, which could help reduce hospitalizations due to asthma.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have certain lung diseases like chronic obstructive pulmonary disease (COPD), cystic fibrosis, or alpha 1 anti-trypsin deficiency.You are between 12 and 75 years old when you join the study.You have been diagnosed with mild or moderate persistent asthma and have been using certain medications for at least 6 months.You have been in the intensive care unit for asthma in the past year.You haven't been taking your prescribed asthma medication as directed, such as missing refills or having a low score on a medication adherence test.If you are between 12 and 17 years old and your asthma is partially controlled or moderately uncontrolled, you may be eligible to participate.
Frequently Asked Questions
To what condition is As needed inhaled corticosteroid and long-acting beta-agonist most frequently recommended?
"Acute coryza can be managed by the use of As-needed inhaled corticosteroid and long-acting beta-agonist. This medication has also been proven to ameliorate nasal congestion, proteinuria, and Crohn's disease."
Who meets the qualifications to participate in this experiment?
"This clinical trial is accommodating 60 individuals, aged 18 to 75 years old, with uncompliant medication for moderate or mild persistent asthma. To be eligible for the study, candidates must fulfill the following criteria: Be capable of comprehending and giving informed consent., Fall between age from eighteen to seventy-five when participating in the experiment., Have a provider diagnosed light or medium lasting bronchial asthma and has been given maintenance ICS treatment plus as needed SABA at least 6 months before enrollment., Inferior adherence to prescribed maintenance ICS therapy specified by missing at least anticipated two ICS refills during prior six months based on pharmacy records inspection"
Is this research initiative recruiting geriatric individuals?
"In accordance with this trial's entry requirements, the minimal age of enrollment is 18 while no patient above 75 can take part."
Is this research undertaking presently open to recruitment?
"Affirmative. Information available on clinicaltrials.gov attests to the fact that this medical trial, which was inaugurated on December 16th 2021 is actively recruiting participants for a 60 person cohort at one research site."
What is the current enrollment capacity of this trial?
"Affirmative, the clinical trial is still accepting applications. Documents posted on clinicaltrials.gov indicate that this research opened for enrollment on December 16th 2021 and was last updated a day later. The investigators are looking to recruit 60 individuals from one medical centre."
Have any other experiments been conducted to determine the efficacy of As needed inhaled corticosteroid and long-acting beta-agonist?
"Presently, 32 studies are being conducted for As needed inhaled corticosteroid and long-acting beta-agonist; 11 of which have reached the third phase. While most research is situated in Xi'an, Shaanxi, there are 998 sites across the world assessing this novel therapy."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger